Redefining the Future of Heart Failure Treatment
The Corisma MCS Pump is a fully implanted trans catheter system designed to improve quality of life with unprecedented simplicity.
Born in the Bonde Artificial Heart Lab at Yale University
For too long, advanced heart failure has meant choosing between immense risk and limited quality of life. Corisma was founded to change that. Spun out from the innovative Bonde Artificial Heart Lab at Yale University, we are redefining what’s possible with a fully implanted trans catheter system that aims to make today’s standard of care obsolete. Our mission is to offer a more dignified empowering solution.
Challenging the Status Quo of Heart Failure Treatment
This device us under development and not yet approved.
Innovation with a Conscience
Mission
To alleviate the suffering caused by advanced heart failure by providing a safer, less invasive, and more dignified treatment option for patients and their families.
Vision
To set a new global standard for heart failure therapy, improving outcomes, enhancing quality of life, and reducing the overall burden on healthcare systems.
A Revolution in Healthcare
The Future of Heart Failure Care, Rooted in Yale’s Legacy
A Paradigm Shirt in Mechanical Circulatory Support
Ending the Era of Sternotomy
Our catheter-based approach challenges the necessity of highly invasive open-heart surgery.
Cutting the Cord
We’ve eliminated the driveline, the biggest compromise in current device technology, to truly set patients free.
Intelligent Hydraulic Support
A pump designed not just to move blood, but to do so with unparalleled physiological compatibility.
The Clinic Comes to You
Remote monitoring transforms patient care from reactive to proactive, ensuring constant support.
From Surgical Insight to Technological Innovation
The seed for Corisma was planted in the operating room. Our founder, Dr. Pramod Bonde, a cardiac surgeon at Yale New Haven Hospital, witnessed firsthand the immense trauma of open-heart surgery and the challenges patients faced with existing mechanical circulatory support devices - particularly the life-limiting risk of driveline infections.
Dr. Bonde asked a simple but powerful question: “What if we could support a failing heart without breaking the chest? What if we could eliminate the driveline entirely?”
These questions drove the research in the Bonde Artificial Heart Lab at Yale University. For years, the team explored trans catheter approaches and wireless energy transmission, pioneering the core technologies that world become the Corisma system. Corisma was officially spun out of Yale to translate this groundbreaking academic research into a life-changing commercial product.
Pramod Bonde MD
Inventor & Founder
Meet the Team
Pramod Bonde MD
Inventor & Founder
Kaushik Mandal MD
Chairman
R. William Vogel
Chief Executive Officer